Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 424/153.1
Name: Drug, bio-affecting and body treating compositions > Immunoglobulin, antiserum, antibody, or antibody fragment, except conjugate or complex of the same with nonimmunoglobulin material > Monoclonal antibody or fragment thereof (i.e., produced by any cloning technology) > Binds eukaryotic cell or component thereof or substance produced by said eukaryotic cell > Hematopoietic cell
Description: Subject matter wherein the cell is a hematopoietic cell.










Sub-classes under this class:

Class Number Class Name Patents
424/154.1 T lymphocytic cell (e.g., t cell, thymocyte, etc.) 406


Patents under this class:
1 2 3 4 5 6 7 8 9

Patent Number Title Of Patent Date Issued
8686119 Variants of humanized immunomodulatory monoclonal antibodies Apr. 1, 2014
8679500 Compositions containing antibodies for treating CD5+ HLA-DR+ B or T cell related diseases Mar. 25, 2014
8663634 Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity Mar. 4, 2014
8663641 Anti-PSGL-1 antibodies Mar. 4, 2014
8647625 Anti-CD154 antibodies Feb. 11, 2014
8647624 Treatment of immune disorders with anti-CD70 antibody Feb. 11, 2014
8637032 Antagonist anti-CD40 monoclonal antibodies and methods for their use Jan. 28, 2014
8637028 Adjuvant incorporation in immunonanotherapeutics Jan. 28, 2014
8632775 Apoptotic anti-IgE antibodies Jan. 21, 2014
8623830 Compositions containing .alpha.-1-antitrypsin and methods for use Jan. 7, 2014
8617554 Anti-human CD52 immunoglobulins Dec. 31, 2013
8613926 Anti-C5a receptor antibodies Dec. 24, 2013
8591900 Anti-CD40 antibodies Nov. 26, 2013
8586040 Methods of using apoptotic anti-IGE antibodies Nov. 19, 2013
8568725 Method of treating transplant rejection with an anti-CD40 antibody Oct. 29, 2013
8562997 Methods of treating acute myeloid leukemia by blocking CD47 Oct. 22, 2013
8557244 Treatment of aggressive non-Hodgkins lymphoma with anti-CD20 antibody Oct. 15, 2013
8557240 Method for the treatment of inflammatory disorders Oct. 15, 2013
8551485 Anti-CD40 antibodies and methods of inhibiting proliferation of CD40 expressing cells Oct. 8, 2013
8545843 Treatment of vasculitis Oct. 1, 2013
8529903 Anti-RhD monoclonal antibodies Sep. 10, 2013
8529902 Human monoclonal antibodies against CD20 Sep. 10, 2013
8530627 Fc.gamma.RIIB specific antibodies and methods of use thereof Sep. 10, 2013
8524236 Methods of antagonizing the binding of CD40 to CD40L with CD40L-specific monovalent polypeptides in autoimmune individuals Sep. 3, 2013
8524867 Optimized antibodies that target CD19 Sep. 3, 2013
RE44389 Methods of inhibiting the binding of P-selectin to PSGL-1 with anti-P-selectin antibodies Jul. 23, 2013
8486394 Generation and Profiling of fully human hucal gold-derived therapeutic antibodies specific for human CD38 Jul. 16, 2013
8486395 Anti-CD19 antibodies Jul. 16, 2013
8481683 Human antibodies that bind CD22 and uses thereof Jul. 9, 2013
8475793 Engineered anti-TSLPR antibodies Jul. 2, 2013
8465741 Antibodies and methods for making and using them Jun. 18, 2013
8461304 Antibodies Jun. 11, 2013
8455622 Variant target binding agents and uses thereof Jun. 4, 2013
8445645 Identification and engineering of antibodies with variant Fc regions and methods of using same May. 21, 2013
8435517 Compositions and methods for treating IgE-mediated disorders May. 7, 2013
8425912 Immunoconjugates with an intracellularly-cleavable linkage Apr. 23, 2013
8409572 Monoclonal antibodies with enhanced ADCC function Apr. 2, 2013
8404241 Anti-rhesus D monoclonal antibody Mar. 26, 2013
8399618 Immunoglobulin insertions, deletions, and substitutions Mar. 19, 2013
8399250 Anti-mpl ligand (thromobpoietin) antibodies Mar. 19, 2013
8388971 Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses Mar. 5, 2013
8388970 KIR-binding agents and methods of use thereof Mar. 5, 2013
8389704 Binding members for IgE molecules Mar. 5, 2013
8388955 Fc variants Mar. 5, 2013
8383109 Optimized Fc variants and methods for their generation Feb. 26, 2013
8377435 Antibody induced cell membrane wounding Feb. 19, 2013
8367805 Fc variants with altered binding to FcRn Feb. 5, 2013
8362210 Antibody variants with enhanced complement activity Jan. 29, 2013
8361472 Anti-PSGL-1 antibodies Jan. 29, 2013
8361471 Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody Jan. 29, 2013

1 2 3 4 5 6 7 8 9










 
 
  Recently Added Patents
Illuminating waveguide fabrication method
Over the counter medicinal container with surface ornamentation
Process to increase selectivity to ethylene in oxygenates-to-olefins conversions
Techniques for generating and displaying a visual flow of user content through a social network
Pulsed plasma with low wafer temperature for ultra thin layer etches
Controller with screen
Transporting business intelligence objects between business intelligence systems
  Randomly Featured Patents
Heat exchanger baffle system
Collapsible lockable support frame assembly and locking mechanism used therein
Centrifuge with chatter suppression
Hydrogen storage and release system
Image forming apparatus and method
Durable sealing curtain
Home device authentication system and method
Magnetic nanoparticle compositions and methods
Solid immersion lens and sample observation method using it
Method and means of linking sausage